The Growth of Smart Technology: Futility in Privacy Regulation and Policy

Smart technology is bringing new found innovation into our everyday lives. However, many are uninformed about how much personal information is being gathered from these new technologies and what these companies are allowed to do with this material. Consumers are discovering the sale of their personal information to third party vendors without their consent, such as the class action lawsuit recently filed: STRADER v. VIZIO, INC. In this case the plaintiff, Trent Strader, is alleging that the television company Vizio is collecting personal identifying information and disclosing it to third party vendors without consent. This allows these vendors to target ads to the consumer that share the same home network as the smart TV1. Privacy concerns over smart technology could also hinder the development of smart cities. Private homes will need to be linked to the smart city’s network which could make the concept of a smart city unappealing to many if the security and disclosure of personal information continues to remain without legal policy in place2. As the growth of smart technology continues, consumers will become more informed and familiar with the technology they use. Because of this, privacy and security issues will undergo even more scrutiny from the public eye. Until policy regarding the regulation of personal information gathered from smart technology is established, the acceptance of this technology will be hampered by negative public opinion.


  • Strader v. Vizio, Inc., 1:16-cv-00381 Retrieved from:
  • Bartoli, A., J. Hernandez-Serrano, M. Soriano, M. Dohler, A. Kountouris, and D. Barthel. “On the Effectiveness of Today’s Privacy Regulations for Secure Smart City Networks.” Centre Tecnologic De Telecomunicacions De Catalunya (CTTC). (2012): 1-6. Retrieved from:

Information Technology and Personalized Medicine: Leading a Healthcare Revolution

Technological advancements have allowed those in the healthcare industry to improve how they keep not only health information, but how they treat their patients as well. Until the last decade, personalized medicine seemed as if it came out of a science fiction novel. Now personalized medicine appears to be the answer to revolutionize the healthcare industry in a time where demand for care continues to grow while supply stays stagnant. Having the ability to track and understand a disease at its earliest stages opens the door from more efficient yet cheaper care. With the rapid expansion of technological advancements in personalized medicine in the last 10 years, many types of melanomas and leukemia diagnoses are offered as a “molecular diagnosis”1. Genotyping the drugs administered with these treatments has also allowed the ability to reduce and study harmful side effects. Childhood obesity is a side effect from a routinely administered chemotherapy drug for patients with acute lymphoblastic leukemia. Understanding the genomic makeup of these individuals can limit and prevent this side effect rather than the previous “one size fits all” treatment.2 Personalized medicine gives physicians the ability to focus on prevention, choose the ideal type of treatment, improve quality of life and costs, and administer the most effective type of therapy1. Information technologies role on the development of personalized medicine is leading a healthcare revolution.

(1). The Case for Personalized Medicine. (2015). Personalized Medicine Coalition, 4(1), 1-68. Retrieved February 5, 2016, from

(2.) Iughetti, L., Bruzzi, P., Predieri, B., & Paolucci, P. (2012). Obesity in patients with acute lymphoblastic leukemia in childhood. Italian Journal of Pediatrics, 38, 4.